Evidence map›Paper›PMID 37443807›Full record

Trial reportCells2023

Effects of an Intervention with Selenium and Coenzyme Q

Urban Alehagen, Jan Alexander, Jan O Aaseth, Anders Larsson, Erland Svensson, Trine B Opstad

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Serum CD5L Responds Positively to Selenium and Coenzyme QAntioxidants (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Urban AlehagenDivision of Cardiovascular Medicine, Department of Medical and Health Sciences, Linköping University, 581 85 Linköping, Sweden.
Jan AlexanderNorwegian Institute of Public Health, 0213 Oslo, Norway.ORCID 0000-0002-6381-5720
Jan O AasethDepartment of Research, Innlandet Hospital Trust, 2382 Brumunddal, Norway.ORCID 0000-0002-7518-5703
Anders LarssonDepartment of Medical Sciences, Uppsala University, 751 85 Uppsala, Sweden.ORCID 0000-0003-3161-0402
Erland SvenssonSwedish Defence Research Agency, 164 40 Stockholm, Sweden (Ret.).
Trine B OpstadCentre for Clinical Heart Research, Department of Cardiology, Oslo University Hospital Ullevål, 0450 Oslo, Norway.
Innlandet Hospital Trust · NOLinköping University · SENorwegian Institute of Public Health · NOOslo University Hospital · NOSwedish Defence Research Agency · SEUppsala University · SE

Funding

Linköping University n/aPharma Nord ApS, Vejle, Denmark n/a
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgingSeleniumUbiquinoneAdiponectinAgedBiomarkersCardiovascular DiseasesDietary SupplementsFemaleHumansIntercellular Adhesion Molecule-1MaleProspective StudiesScandinavians and Nordic PeopleSwedenAdiponectinBiomarkerscoenzyme Q10Intercellular Adhesion Molecule-1SeleniumUbiquinonebiomarkerscoenzyme Q10elderlymortalityseleniumSEM

Identifiers

PMID37443807
PMCPMC10340529
OpenAlexW4383262948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.